Grifols (GRF)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

€  18.75
   
  • 52 Week High: € 19.48
  • 52 Week Low: € 11.11
  • Currency: Euro
  • Shares Issued: 212.91m
  • Market Cap: € 3,992.00m
  • RiskGrade: 156
  • Beta: 0.44

Grifols Overview

GRIFOLS is a Spain-based drug manufacturer whose primary activites are the manufacturing of therapeutic products.

3 Month Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 15.5%
ROCE 4.7%
Latest F'cast
P/E 98.7
PEG n/a
Pr/Revenue 2.2
Pr/Book 2.4
Latest F'cast
Revenue 81.2%
PBT -49.3%
EPS -64.8%
DPS n/a

Grifols Fundamentals

Year Ending Revenue (€ m) Pre-tax (€ m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 703.29 123.59 41.40¢ 37.2 0.5 +70% 11.70¢ 0.8%
31-Dec-08 814.31 172.27 57.77¢ 21.3 0.5 +40% 23.00¢ 1.9%
31-Dec-09 913.19 203.99 71.00¢ 17.2 0.7 +23% 15.00¢ 1.2%
31-Dec-10 990.73 157.78 54.00¢ 18.9 n/a -24% 13.00¢ 1.3%
31-Dec-11 1,795.61 80.02 19.00¢ 68.4 n/a -65% n/a 0.0%

Grifols Forecasts

Year Ending Revenue (€ m) Pre-tax (€ m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 2,547.05 402.36 91.92¢ 20.4 0.1 +384% 11.60¢ 0.6%
31-Dec-13 2,742.60 529.79 115.96¢ 16.2 0.6 +26% 24.23¢ 1.3%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Grifols Market Data

Currency Euro
% Change 1.08 %
52 Week High € 19.48
52 Week Low € 11.11
Shares Issued 212.91m
Market Cap € 3,992.00m
Beta 0.44
RiskGrade 156

What The Brokers Say

Strong Buy 8
Buy 1
Neutral 9
Sell 3
Strong Sell 2
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page